Identification of sulfonamide-based butyrylcholinesterase inhibitors using machine learning
| dc.contributor.author | Ganeshpurkar A.; Singh R.; Kumar D.; Gutti G.; Gore P.; Sahu B.; Kumar A.; Singh S.K. | |
| dc.date.accessioned | 2025-05-23T11:23:15Z | |
| dc.description.abstract | Aim: This study reports the designing of BChE inhibitors through machine learning (ML), followed by in silico and in vitro evaluations. Methodology: ML technique was used to predict the virtual hit, and its derivatives were synthesized and characterized. The compounds were evaluated by using various in vitro tests and in silico methods. Results: The gradient boosting classifier predicted N-phenyl-4-(phenylsulfonamido) benzamide as an active BChE inhibitor. The derivatives of the inhibitor, i.e., compounds 34, 37 and 54 were potent BChE inhibitors and displayed blood-brain barrier permeability with no significant AChE inhibition. Conclusion: The ML prediction was effective, and the synthesized compounds showed the BChE inhibitory activity, which was also supported by the in silico studies. © 2022 Newlands Press. | |
| dc.identifier.doi | https://doi.org/10.4155/fmc-2021-0325 | |
| dc.identifier.uri | http://172.23.0.11:4000/handle/123456789/8816 | |
| dc.relation.ispartofseries | Future Medicinal Chemistry | |
| dc.title | Identification of sulfonamide-based butyrylcholinesterase inhibitors using machine learning |